Does VENETOCLAX Cause Neoplasm malignant? 361 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 361 reports of Neoplasm malignant have been filed in association with VENETOCLAX (Venclexta). This represents 0.7% of all adverse event reports for VENETOCLAX.
361
Reports of Neoplasm malignant with VENETOCLAX
0.7%
of all VENETOCLAX reports
58
Deaths
118
Hospitalizations
How Dangerous Is Neoplasm malignant From VENETOCLAX?
Of the 361 reports, 58 (16.1%) resulted in death, 118 (32.7%) required hospitalization, and 2 (0.6%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VENETOCLAX. However, 361 reports have been filed with the FAERS database.
What Other Side Effects Does VENETOCLAX Cause?
Death (9,412)
Off label use (6,252)
Neutropenia (3,041)
Febrile neutropenia (2,663)
Platelet count decreased (2,367)
Pyrexia (2,351)
Pneumonia (2,300)
Fatigue (2,281)
Diarrhoea (2,082)
White blood cell count decreased (1,913)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which VENETOCLAX Alternatives Have Lower Neoplasm malignant Risk?
VENETOCLAX vs VENLAFAXINE
VENETOCLAX vs VENTAVIS
VENETOCLAX vs VENTOLIN
VENETOCLAX vs VENTOLIN HFA
VENETOCLAX vs VERAPAMIL